Clare Ozawa is a Managing Director at Versant Ventures. She previously held leadership roles at Inception Sciences and worked at Novartis Pharma and McKinsey & Company.
At firms with a similar stage, sector and check size.




One email when Clare's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckClare Ozawa is a Managing Director at Versant Ventures. She previously held leadership roles at Inception Sciences and worked at Novartis Pharma and McKinsey & Company.
Versant Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Versant Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
founding chief business officer at Inception Sciences; COO at Inception Sciences; McKinsey & Company; Novartis Pharma; founding chief business officer at Inception; COO at Inception.
Last updated 2026-10-15. Is this you? Ask for a correction.